Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Biomarkers of Response to Ketamine in Depression

To see complete record on, please visit this link

Id: NCT04216888

Organisation Name: Nathan Kline Institute for Psychiatric Research

Overal Status: Completed

Start Date: June 26, 2019

Last Update: January 22, 2021

Lead Sponsor: Dan Iosifescu

Brief Summary: This pilot study aims to identify predictors of response to intranasal ketamine treatment in patients with treatment-resistant depression. Participants will give a sample of blood and undergo magnetic resonance imaging before and after a single intranasal ketamine treatment. Participants will subsequently receive a second intranasal ketamine treatment.

  • Depressive Disorder, Treatment-Resistant

Total execution time in seconds: 0.21928000450134